Pharmaceutical excipients expert Roquette has signed an agreement with the MCG Group for the shares of hard capsule manufacturer Qualicaps
The Mitsubishi Chemical Group (the MCG Group) has announced the signature of a share transfer agreement with Roquette, specialist in pharmaceutical excipients headquartered in France, for the transfer of all shares of Qualicaps. The transaction is expected to close by the end of 2023.
Founded in 1965 and headquartered in Yamatokoriyama, Nara, Japan, Qualicaps is a manufacturer of hard capsules and pharmaceutical related equipment. The company has the largest share of the hard capsule market in Japan and one of the largest in the world.
The company also boasts the top domestic market share in the field of pharmaceutical related equipment. In 2014, Mitsubishi Chemical Holding (now Mitsubishi Chemical Group) acquired shares and became a shareholder of Qualicaps.
Qualicaps will continue to offer high quality, highly regarded products and services, and will strive to strengthen its value proposition to customers through a creative approach
- Qualicaps CEO, Seiichiro Matsumura
Founded in 1933, Roquette is a family-owned global leader of plant-based ingredients and provider of pharmaceutical excipients. The company currently operates in more than 100 countries, has a turnover of around USD $5.3bn, and employs more than 8,000 people worldwide. Roquette’s large portfolio includes pharmaceutical solutions that play a key role in medical treatments or innovative ingredients for food, nutrition and health markets.
The combination of the two businesses will bring new opportunities for Roquette and Qualicaps customers and employees. This strategic investment will allow to create a stronger leader, with an expanded global footprint, as well as an enriched offering of oral dosage solutions. Qualicaps’ expertise, infrastructure, and assets will be completed by Roquette’s deep knowledge and expertise in the pharmaceutical industry.
The newly combined business will offer the most diverse range of oral dosage solutions to existing and new customers, addressing their current needs and anticipating future ones through new and even more innovative solutions. The closing of the acquisition of Qualicaps by Roquette is expected to occur between October and December, 2023.
The closing remains subject to the fulfillment of some customary conditions and, until then, Qualicaps remains 100% owned and managed by the Mitsubishi Chemicals Group (MCG).
On the occasion of this signature, Qualicaps CEO Seiichiro Matsumura said: “Under the new owner; Roquette, Qualicaps will continue to offer high quality, highly regarded products and services, and will strive to strengthen its value proposition to customers through a creative approach. We are looking forward to this partnership as a keyway to further develop Qualicaps.”